Pretomanid

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

A Pan-TB Regimen Targeting Host and Microbe

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Economic Evaluation of New MDR TB Regimens

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

PRACTECAL-PKPD Sub Study